| Bioactivity | Rosopatamab (HJ 591) is a humanised anti-PSMA monoclonal antibody that can be used in cancer research, particularly in prostate cancer[1][2]. |
| Target | PSMA. |
| Name | Rosopatamab |
| CAS | 2260767-49-3 |
| Appearance | Liquid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Keun Ho Lee, et al. Antibody-payload conjugates with enhanced delivery domain and uses thereof. Patent WO2021092672A1. [2]. Antonini P, et al. 177Lu-DOTA-TLX591 safety, biodistribution and dosimetry study (ProstACT-SELECT)[J]. 2022. |